Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery

BACKGROUND: Conventional treatment for locally advanced rectal cancer usually combines neoadjuvant radiochemotherapy and surgery. Until recently, there have been limited predictive factors (clinical or biological) for rectal tumor response to conventional treatment. KRAS, BRAF and PIK3CA mutations a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Derbel, Olfa, Wang, Qing, Desseigne, Françoise, Rivoire, Michel, Meeus, Pierre, Peyrat, Patrice, Stella, Mattia, Martel-Lafay, Isabelle, Lemaistre, Anne-Isabelle, de La Fouchardière, Christelle
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3640970/
https://ncbi.nlm.nih.gov/pubmed/23617638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-200
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi